当前位置: X-MOL 学术J. Urol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions.
The Journal of Urology ( IF 6.6 ) Pub Date : 2024-02-14 , DOI: 10.1097/ju.0000000000003890
Todd M. Morgan 1 , Stephen A. Boorjian 2 , Mark K. Buyyounouski 3 , Brian F. Chapin 4 , David Y. T. Chen 5 , Heather H. Cheng 6 , Roger Chou 7 , Heather A. Jacene 6 , Sophia C. Kamran 8 , Sennett K. Kim 9 , Erin Kirkby 9 , Amy N. Luckenbaugh 10 , Ben J. Nathanson , Yaw A. Nyame 11 , Edwin M. Posadas 12 , Phuoc T. Tran 13 , Ronald C. Chen 14
Affiliation  

The summary presented herein covers recommendations on salvage therapy for recurrent prostate cancer intended to facilitate care decisions and aid clinicians in caring for patients who have experienced a recurrence following prior treatment with curative intent. This is Part III of a three-part series focusing on evaluation and management of suspected non-metastatic recurrence after radiotherapy (RT) and focal therapy, evaluation and management of regional recurrence, management for molecular imaging metastatic recurrence, and future directions. Please refer to Part I for discussion of treatment decision-making and Part II for discussion of treatment delivery for non-metastatic biochemical recurrence (BCR) after radical prostatectomy (RP).

中文翻译:

前列腺癌的挽救治疗:AUA/ASTRO/SUO 指南第三部分:放射治疗或局部治疗后的挽救治疗、盆腔淋巴结复发和寡转移以及未来方向。

本文提出的总结涵盖了复发性前列腺癌挽救治疗的建议,旨在促进护理决策并帮助临床医生护理在先前以治愈为目的的治疗后经历复发的患者。这是三部分系列的第三部分,重点关注放疗 (RT) 和局部治疗后疑似非转移性复发的评估和管理、区域复发的评估和管理、分子影像转移性复发的管理以及未来方向。请参阅第一部分关于治疗决策的讨论,以及第二部分关于根治性前列腺切除术(RP)后非转移性生化复发(BCR)治疗实施的讨论。
更新日期:2024-02-14
down
wechat
bug